Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Amortizatization of Intangibles: 2019-2025

Historic Amortizatization of Intangibles for BridgeBio Pharma (BBIO) over the last 7 years, with Sep 2025 value amounting to -$49.7 million.

  • BridgeBio Pharma's Amortizatization of Intangibles fell 8705.50% to -$49.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year increase of 203.41%. This contributed to the annual value of $15.8 million for FY2024, which is 76.97% up from last year.
  • Latest data reveals that BridgeBio Pharma reported Amortizatization of Intangibles of -$49.7 million as of Q3 2025, which was down 280.82% from $27.5 million recorded in Q2 2025.
  • In the past 5 years, BridgeBio Pharma's Amortizatization of Intangibles registered a high of $27.5 million during Q2 2025, and its lowest value of -$49.7 million during Q3 2025.
  • Over the past 3 years, BridgeBio Pharma's median Amortizatization of Intangibles value was $2.2 million (recorded in 2023), while the average stood at $2.6 million.
  • The largest annual percentage gain for BridgeBio Pharma's Amortizatization of Intangibles in the last 5 years was 1,546.58% (2025), contrasted with its biggest fall of 8,705.50% (2025).
  • BridgeBio Pharma's Amortizatization of Intangibles (Quarterly) stood at $1.8 million in 2021, then rose by 19.92% to $2.1 million in 2022, then climbed by 3.90% to $2.2 million in 2023, then spiked by 479.20% to $12.6 million in 2024, then slumped by 8,705.50% to -$49.7 million in 2025.
  • Its Amortizatization of Intangibles was -$49.7 million in Q3 2025, compared to $27.5 million in Q2 2025 and $25.6 million in Q1 2025.